The National Academies of Sciences, Engineering, and Medicine (NASEM) and the Biotechnology Innovation Organization will hold a public webinar titled "Human Genome Editing — Latest Developments and Advancements". The webinar will discuss issues and recommendations discussed in the 2017 NASEM report on human genome editing, breakthroughs and next steps in gene editing of somatic cells, and the regulatory framework for therapies that make use of genome editing.
Key participants in the webinar will include:
- Matthew Porteus, Stanford University (consensus study committee member)
- Sandy Macrae, Sangamo Therapeutics
- Peter Marks, U.S. Food and Drug Administration
An audience Q&A will follow the presentation.